Breast cancer estrogens conjugated usp. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Nipples Lymph Nodes Neoplastic Stem Cells Epithelial Cells Neoplastic Cells, Circulating Mammary Glands, Animal Uterus Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases40

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Neoplasms, Hormone-Dependent Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Mammary Neoplasms, Experimental Carcinoma Lymphatic Metastasis Ovarian Neoplasms Neoplasm Recurrence, Local Fibrocystic Breast Disease Lung Neoplasms Disease Progression Neoplasms Prostatic Neoplasms Bone Neoplasms Colonic Neoplasms Cell Transformation, Neoplastic Carcinoma, Ductal Carcinoma in Situ Triple Negative Breast Neoplasms Stomach Neoplasms Neoplasms, Second Primary Adenocarcinoma Inflammatory Breast Neoplasms Endometrial Neoplasms Fibroadenoma Pancreatic Neoplasms Neovascularization, Pathologic Uterine Cervical Neoplasms Neoplastic Cells, Circulating Neoplasms, Basal Cell Mammary Neoplasms, Animal Colorectal Neoplasms Neoplasms, Radiation-Induced

Chemicals and Drugs66

Estrogens Receptors, Estrogen Estrogen Receptor alpha Estrogen Receptor beta Tamoxifen Receptors, Progesterone Receptor, erbB-2 Estradiol Estrogens, Conjugated (USP)Antineoplastic Agents, Hormonal Tumor Markers, Biological Ubiquitin Thiolesterase Ubiquitin-Specific Proteases Selective Estrogen Receptor Modulators Neoplasm Proteins Antineoplastic Agents RNA, Messenger Aromatase Inhibitors Estrogens, Catechol BRCA2 Protein BRCA1 Protein Estrogen Antagonists RNA, Small Interfering DNA, Neoplasm Estrogens, Non-Steroidal Aromatase Fluorouracil Estrone Tumor Suppressor Protein p53 Antibodies, Monoclonal, Humanized Cyclophosphamide Progestins Epirubicin Estrogen Receptor Modulators Ki-67 Antigen Antibodies, Monoclonal Tumor Suppressor Proteins Transcription Factors Receptor, Epidermal Growth Factor Nitriles Triazoles RNA, Neoplasm Paclitaxel Anticarcinogenic Agents Diethylstilbestrol Estradiol Congeners DNA-Binding Proteins Endopeptidases Antigens, Neoplasm Cancer Vaccines Phytoestrogens Antigens, CD24 Mucin-1 MicroRNAs Nuclear Proteins Proto-Oncogene Proteins c-akt Anthracyclines Receptors, Androgen Hydroxyestrones Cyclin D1 Antibiotics, Antineoplastic Progesterone Proto-Oncogene Proteins DNA Primers Androgens Gonadal Steroid Hormones

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Mammography Prognosis Neoplasm Staging Risk Factors Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Immunohistochemistry Case-Control Studies Mammary Neoplasms, Experimental Gene Expression Profiling Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Risk Breast Self-Examination Follow-Up Studies Ovariectomy Survival Rate Prospective Studies Risk Assessment Blotting, Western Retrospective Studies Odds Ratio Mastectomy, Segmental Incidence Treatment Outcome Xenograft Model Antitumor Assays Cohort Studies Multivariate Analysis Oligonucleotide Array Sequence Analysis Registries Sensitivity and Specificity Neoplasm Transplantation Transplantation, Heterologous Transfection Ultrasonography, Mammary Tissue Array Analysis Predictive Value of Tests Kaplan-Meier Estimate SEER Program Logistic Models Questionnaires Tumor Burden Polymerase Chain Reaction Immunoenzyme Techniques Combined Modality Therapy Breast Implants Reproducibility of Results Gene Knockdown Techniques Neoplasm Grading Confidence Intervals Radiotherapy, Adjuvant Mass Screening Neoadjuvant Therapy Clinical Trials as Topic Mammaplasty Proportional Hazards Models Drug Screening Assays, Antitumor Drug Administration Schedule Hormone Replacement Therapy Models, Biological Molecular Targeted Therapy Genetic Testing Biopsy, Needle Radiotherapy Sentinel Lymph Node Biopsy Biopsy Estrogen Replacement Therapy In Situ Hybridization, Fluorescence Lymph Node Excision Mastectomy, Radical DNA Mutational Analysis

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Postmenopause Genes, BRCA1 Premenopause Menopause Drug Resistance, Neoplasm Cell Proliferation Genetic Predisposition to Disease Breast Feeding Risk Signal Transduction Genes, BRCA2 Genes, erbB-2 Odds Ratio Time Factors Apoptosis Mutation Cell Division Promoter Regions, Genetic Sensitivity and Specificity Down-Regulation Cell Movement Dose-Response Relationship, Drug Transfection Genotype Polymorphism, Genetic Germ-Line Mutation RNA Interference Cell Growth Processes Up-Regulation Gene Expression Cell Cycle DNA Methylation Base Sequence Gene Amplification Transcription, Genetic Phosphorylation Gene Silencing Parity Cell Survival Phenotype Genes, Tumor Suppressor Genes, Neoplasm Protein Binding Alleles Epithelial-Mesenchymal Transition Diet Genes, p53 Polymorphism, Single Nucleotide Ubiquitination Heterozygote

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care31

Risk Factors Case-Control Studies Survival Analysis Disease-Free Survival Risk Follow-Up Studies Survival Rate Prospective Studies Risk Assessment Age Factors Retrospective Studies Odds Ratio Incidence Treatment Outcome Cohort Studies Multivariate Analysis Registries Sensitivity and Specificity Predictive Value of Tests Kaplan-Meier Estimate SEER Program Logistic Models Questionnaires Reproducibility of Results Confidence Intervals Mass Screening Clinical Trials as Topic Parity Proportional Hazards Models Genetic Testing National Cancer Institute (U.S.)

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Estrogens Receptors, Estrogen Breast Estrogen Receptor alpha Breast Neoplasms Carcinoma, Ductal, Breast Estrogen Receptor beta Tamoxifen Cell Line, Tumor Receptors, Progesterone Receptor, erbB-2 Estradiol Breast Diseases Gene Expression Regulation, Neoplastic Mammography Estrogens, Conjugated (USP)Neoplasm Metastasis Neoplasm Invasiveness Prognosis Antineoplastic Agents, Hormonal Tumor Markers, Biological Ubiquitin Thiolesterase Postmenopause Breast Neoplasms, Male Ubiquitin-Specific Proteases Selective Estrogen Receptor Modulators Neoplasm Staging Risk Factors Neoplasm Proteins Mastectomy Antineoplastic Agents Early Detection of Cancer Genes, BRCA1 Carcinoma, Lobular Chemotherapy, Adjuvant Neoplasms, Hormone-Dependent MCF-7 Cells Tumor Cells, Cultured Premenopause Carcinoma, Intraductal, Noninfiltrating Menopause Mice, Nude Immunohistochemistry Drug Resistance, Neoplasm Cell Proliferation RNA, Messenger Genetic Predisposition to Disease Case-Control Studies Mammary Neoplasms, Experimental Aromatase Inhibitors Gene Expression Profiling Survival Analysis Carcinoma Reverse Transcriptase Polymerase Chain Reaction Breast Feeding Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Lymphatic Metastasis Risk Ovarian Neoplasms Breast Self-Examination Follow-Up Studies Neoplasm Recurrence, Local Estrogens, Catechol Ovariectomy BRCA2 Protein Survival Rate BRCA1 Protein Signal Transduction Prospective Studies Genes, BRCA2 Risk Assessment Age Factors Fibrocystic Breast Disease Blotting, Western Lung Neoplasms Retrospective Studies Disease Progression Genes, erbB-2 Odds Ratio Estrogen Antagonists Mastectomy, Segmental Survivors Axilla Mammary Glands, Human Neoplasms Incidence Prostatic Neoplasms Treatment Outcome RNA, Small Interfering Time Factors Apoptosis Mutation DNA, Neoplasm Xenograft Model Antitumor Assays Estrogens, Non-Steroidal Cell Division Cohort Studies Aromatase Multivariate Analysis

No FAQ available that match "breast cancer estrogens conjugated usp"